Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF)

What is Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF)?

Bictegravir-emtricitabine-tenofovir alafenamide is a combination drug used to treat HIV-1 in adults.

Save up to 80% off your prescriptions!

How do members experience Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF)?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 45 19
Diabetes type 2 2 0
Hepatitis B 1 0
HIV exposure 1 0

Common side effects

Side effect Patients Percentage
Headaches 2
Weight gain 2
Calcified tendon 1
Diarrhea 1
Nausea 1
Tension headache 1

Side effect severity

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 3
Mild 6
None 9
Learn more about our community’s experience with Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF)

What are people saying about Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF)?

62

62

members have reported taking Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF)

Join the conversation and connect with people who have taken Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF)
Last updated:

Save up to 80% off your prescriptions!

ADVERTISEMENT

ADVERTISEMENT